Meprin alpha Subunit/MEP1A Antibody (001) [Janelia Fluor® 635]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-90383JF635
Recombinant Monoclonal Antibody
Conjugate
Catalog #
Key Product Details
Species Reactivity
Mouse
Applications
ELISA, Immunohistochemistry-Paraffin
Label
Janelia Fluor 635
Antibody Source
Recombinant Monoclonal Rabbit IgG Clone # 001
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody was obtained from a rabbit immunized with purified, recombinant Mouse Meprin alpha Subunit/MEP1A (Accession#: NP_032611.2; Met 1-Arg 615).
Clonality
Monoclonal
Host
Rabbit
Isotype
IgG
Applications for Meprin alpha Subunit/MEP1A Antibody (001) [Janelia Fluor® 635]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Meprin alpha Subunit/MEP1A
Alternate Names
MEP1A, PPHA
Gene Symbol
MEP1A
Additional Meprin alpha Subunit/MEP1A Products
Product Documents for Meprin alpha Subunit/MEP1A Antibody (001) [Janelia Fluor® 635]
Product Specific Notices for Meprin alpha Subunit/MEP1A Antibody (001) [Janelia Fluor® 635]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...